Jerry K. L. Tan MD, FRCPC
Adjunct Professor, Internal Medicine and Dermatology, Western University, Windsor Campus, Ontario, CanadaJerry K. L. Tan MD FRCPC is an adjunct professor at the University of Western Ontario, the principal investigator of Windsor Clinical Research Inc., and in private practice in Windsor, Ontario, Canada. His MD was obtained at Queen’s University; internal medicine residency at the University of Toronto; and dermatology residency at the Universities of British Columbia and Michigan. His research focus is on acne, rosacea, clinical assessment methodology, patient-reported outcomes and medical decision-making. He was awarded a Canadian Dermatology Foundation grant in 2009 for decision-making and on development of decision aids and was the lead investigator for the Canadian Acne Epidemiology Project. He is the chair of the steering committee of the Canadian Acne Clinical Practice Guidelines project. He has served on the organizing committee of the Canadian Institutes of Health Research workshop on skin disease research priorities and is a therapeutic advisor on evidence-based review panels in Canada and the United States. He is a co-recipient of an NIH grant for development and validation of outcome measures in acne. He serves on the editorial board of various dermatology journals and is the chair of scholarship and co-chair of free communications committees, respectively, of the World Congress of Dermatology 2015. He has published more than 70 scientific articles in peer reviewed journals and has presented research findings at national and international meetings.
Disclosures
Dr. Tan's relevant disclosures (for acne) are: Advisor, consultant, speaker and/or clinical trial investigator for Allergan, Cipher, Dermira, Galderma, Roche, Stiefel/GSK, Valeant
Recent Contributions to PracticeUpdate:
- Outcomes of an Educational Initiative to Improve Acne Health Literacy in Young Adolescents
- Truncal Acne in Adolescents and Young Adults
- The Social and Psychological Impact of Acne Treatment
- QOL Assessment Using Skindex-16 Scores for Patients With Acne Receiving Isotretinoin Treatment
- Modified 5-Aminolevulinic Acid Photodynamic Therapy to Reduce Pain in Moderate to Severe Acne Vulgaris
- Effect of Topical Brimonidine on Alcohol-Induced Flushing in Asians
- Clascoterone Is a Novel Androgen Receptor Antagonist That Inhibits Production of Lipids and Inflammatory Cytokines From Sebocytes in Vitro
- Increased Risk of Cardiovascular Diseases in Female Rosacea Patients
- Isotretinoin Treatment for Acne and Risk of Depression
- Adapalene/BPO Plus Doxycycline vs Oral Isotretinoin for Severe Nodular Acne